Vaxxinity, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 20.46 million compared to USD 47.65 million a year ago. Basic loss per share from continuing operations was USD 0.16 compared to USD 0.48 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.051 USD | -49.00% | -63.86% | -94.00% |
12:00am | Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P Global BMI Index | CI |
12:00am | Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-94.00% | 6.46M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- VAXX Stock
- News Vaxxinity, Inc.
- Vaxxinity, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022